Although these findings do not mean that the CD8+ T-cell response of these infants is not enough to provide protection against measles virus infection, it does indicate that not only neonates but also infants still show altered T-cell responsiveness, which may open a window to infection and/or decreased vaccine efficacy. This evidence concerns the gene CD8A and infection.